Ocugen (OCGN) Free Cash Flow (2014 - 2026)
Ocugen (OCGN) posted Free Cash Flow of -$21.8 million for Q1 2026, down 54.31% on a QoQ basis from -$14.1 million in Q4 2025, and down 12.53% year-over-year from -$24.9 million in Q1 2025.
Ocugen (OCGN) Free Cash Flow (2014 - 2026) Analysis & Trends
Ocugen's Free Cash Flow history runs 13 years deep, the most recent figure standing at -$21.8 million for Q1 2026.
- Quarterly Free Cash Flow fell 12.53% year-over-year to -$21.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$59.6 million (down 14.67% YoY) and the FY2025 annual result came in at -$57.1 million, down 25.53% from the prior year.
- Free Cash Flow was -$21.8 million for Q1 2026 at Ocugen, down from -$14.1 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$5.7 million in Q4 2023 and bottomed at -$21.8 million in Q1 2026.
- A 5-year average of -$14.7 million and a median of -$14.4 million in 2024 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2022 — Free Cash Flow plunged 175.78% — and 2023, when it soared 65.43%.
- Ocugen's Free Cash Flow stood at -$16.6 million in 2022, then surged by 65.43% to -$5.7 million in 2023, then sank by 80.88% to -$10.4 million in 2024, then tumbled by 36.14% to -$14.1 million in 2025, then tumbled by 54.31% to -$21.8 million in 2026.
- Business Quant data shows OCGN's Free Cash Flow at -$21.8 million in Q1 2026, -$14.1 million in Q4 2025, and -$12.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | Ocugen | 63.79 Mn | 63.79 Mn | - | -21.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.80 Mn |
| Mar 31, 2026 | -21.80 Mn |
| Dec 31, 2025 | -14.13 Mn |
| Dec 31, 2025 | -14.13 Mn |
| Sep 30, 2025 | -12.88 Mn |
| Sep 30, 2025 | -12.88 Mn |
| Jun 30, 2025 | -10.77 Mn |
| Jun 30, 2025 | -10.77 Mn |
| Mar 31, 2025 | -19.37 Mn |
| Mar 31, 2025 | -19.37 Mn |
| Dec 31, 2024 | -10.38 Mn |
| Dec 31, 2024 | -10.38 Mn |
| Sep 30, 2024 | -14.40 Mn |
| Sep 30, 2024 | -14.40 Mn |
| Jun 30, 2024 | -7.81 Mn |
| Jun 30, 2024 | -7.81 Mn |
| Mar 31, 2024 | -12.95 Mn |
| Mar 31, 2024 | -12.95 Mn |
| Dec 31, 2023 | -5.74 Mn |
| Dec 31, 2023 | -5.74 Mn |